Abemaciclib in the Adjuvant Setting for Breast Cancer: A Systematic Review
Saadia Ouarrak · Journal of Cancer and Tumor International · 2024
The combination of adjuvant Abemaciclib with endocrine therapy (ET) has emerged as a significant advancement in the management of HR+, HER2-, node-positive, high-risk early breast cancer, as demonstrated by the findings of the MonarchE trial. This innovative treatment approach yi...
Open access
Research Article
10.9734/jcti/2024/v14i2250